Clinical Trial Update: Efficacy and Safety Study of HS-10542 for IgA Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HS-10542 in IgA nephropathy, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• HS-10542

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: IgAN, Immunoglobulin A Nephropathy (IgAN) | Phase 2 | Status: NOT_YET_RECRUITING